157 — Natural Beauty Bio-Technology Cashflow Statement
0.000.00%
Last trade - 00:00- HK$961.01m
- HK$1.06bn
- HK$353.65m
Annual cashflow statement for Natural Beauty Bio-Technology, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 8.98 | 48.5 | -23.5 | -11.9 | -105 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 16.3 | 6.61 | 25.2 | 10.9 | 61.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -32.4 | -45.4 | -24.4 | -3.99 | -1.65 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 30.1 | 44.6 | 11.6 | 21.7 | -13.7 |
| Capital Expenditures | -73.9 | -38.1 | -44.3 | -69.1 | -41.2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 25 | 8.96 | 5.54 | 1.51 | 1.04 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -48.9 | -29.2 | -38.8 | -67.6 | -40.2 |
| Financing Cash Flow Items | -1.79 | -3.88 | -4.89 | -7.02 | -7.46 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 28.1 | 10.4 | 13.2 | 42.6 | 15.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 19 | 29.9 | -23.9 | -1.85 | -49.7 |